Identification of a novel enhancer essential for Satb1 expression in TH2 cells and activated ILC2s

被引:2
|
作者
Nomura, Aneela [1 ]
Kobayashi, Tetsuro [2 ]
Seo, Wooseok [1 ,7 ]
Ohno-Oishi, Michiko [1 ,8 ]
Kakugawa, Kiyokazu [3 ]
Muroi, Sawako [1 ]
Yoshida, Hideyuki [4 ]
Endo, Takaho A. [5 ]
Moro, Kazuyo [2 ,6 ]
Taniuchi, Ichiro [1 ]
机构
[1] RIKEN Ctr Integrat Med Sci IMS, Lab Transcript Regulat, Yokohama, Japan
[2] RIKEN Ctr Integrat Med Sci IMS, Lab Innate Immune Syst, Yokohama, Japan
[3] RIKEN Ctr Integrat Med Sci IMS, Lab Immune Crosstalk, Yokohama, Japan
[4] RIKEN Ctr Integrat Med Sci IMS, Lab YCI Lab Immunol Transcript, Yokohama, Japan
[5] RIKEN Ctr Integrat Med Sci IMS, Lab Integrat Genom, Yokohama, Japan
[6] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Innate Immune Syst, Osaka, Japan
[7] Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Japan
[8] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Japan
关键词
MULTIPLE GENES; SATB1; CHROMATIN;
D O I
10.26508/lsa.202301897
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The genome organizer, special AT-rich binding protein-1 (SATB1), functions to globally regulate gene networks during primary T cell development and plays a pivotal role in lineage specification in CD4' helper-, CD8' cytotoxic-, and FOXP3' regulatory-T cell subsets. However, it remains unclear how Satb1 gene expression is controlled, particularly in effector T cell function. Here, by using a novel reporter mouse strain expressing SATB1-Venus and ge-nome editing, we have identified a cis-regulatory enhancer, es-sential for maintaining Satb1 expression specifically in TH2 cells. This enhancer is occupied by STAT6 and interacts with Satb1 promoters through chromatin looping in TH2 cells. Reduction of Satb1 expression, by the lack of this enhancer, resulted in ele-vated IL-5 expression in TH2 cells. In addition, we found that Satb1 is induced in activated group 2 innate lymphoid cells (ILC2s) through this enhancer. Collectively, these results provide novel insights into how Satb1 expression is regulated in TH2 cells and ILC2s during type 2 immune responses.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] ILC2s masquerade as ILC1s to drive chronic disease
    Belz, Gabrielle T.
    NATURE IMMUNOLOGY, 2016, 17 (06) : 611 - 612
  • [22] ILC2s activated by IL-25 promote antigen-specific Th2 and Th9 functions that contribute to the control of Trichinella spiralis infection
    Angkasekwinai, Pornpimon
    Sodthawon, Wichuda
    Jeerawattanawart, Siranart
    Hansakon, Adithap
    Pattanapanyasat, Kovit
    Wang, Yui-Hsi
    PLOS ONE, 2017, 12 (09):
  • [23] Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer
    Wu, Yumin
    Yan, Yulan
    Su, Zhaoliang
    Bie, Qingli
    Chen, Xiaobo
    Barnie, Prince Amoah
    Guo, Qi
    Wang, Shengjun
    Xu, Huaxi
    MOLECULAR MEDICINE REPORTS, 2017, 15 (06) : 4374 - 4381
  • [24] Allergen-induced bone marrow eosinophilia: Role of ILC2s and TH cells
    Winberg, E.
    Johansson, K.
    Weidner, J.
    Malmhall, C.
    Radinger, M.
    ALLERGY, 2018, 73 : 220 - 220
  • [25] Global Regulator SATB1 Recruits β-Catenin and Regulates TH2 Differentiation in Wnt-Dependent Manner (Publication with Expression of Concern)
    Notani, Dimple
    Gottimukkala, Kamalvishnu P.
    Jayani, Ranveer S.
    Limaye, Amita S.
    Damle, Madhujit V.
    Mehta, Sameet
    Purbey, Prabhat Kumar
    Joseph, Jomon
    Galande, Sanjeev
    PLOS BIOLOGY, 2010, 8 (01)
  • [26] Identifying the expression and function of Blimp-1 in ILC2s in allergic asthma
    Zheng, Yibo
    Zhang, Jinyi
    He, Kun
    Poholek, Amanda C.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [27] Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression
    Savarese, Fabio
    Davila, Amparo
    Nechanitzky, Robert
    De La Rosa-Velazquez, Inti
    Pereira, Carlos F.
    Engelke, Rudolf
    Takahashi, Keiko
    Jenuwein, Thomas
    Kohwi-Shigematsu, Terumi
    Fisher, Amanda G.
    Grosschedl, Rudolf
    GENES & DEVELOPMENT, 2009, 23 (22) : 2625 - 2638
  • [28] A role for IL-33-activated ILC2s in eosinophilic vasculitis
    Kotas, Maya E.
    Dion, Jeremie
    Van Dyken, Steven
    Ricardo-Gonzalez, Roberto R.
    Danel, Claire J.
    Taille, Camille
    Mouthon, Luc
    Locksley, Richard M.
    Terrier, Benjamin
    JCI INSIGHT, 2021, 6 (12)
  • [29] ILC2S WITH TNFR2 EXPRESSION ARE POTENTIAL THERAPEUTIC TARGETS FOR ASTHMA
    Barbers, Richard G.
    Jahani, Pedram Shafiei
    Hurrell, Benjamin P.
    Shen, Stephen
    Helou, Georges Doumet
    Kwong, Kenny
    Baydur, Ahmet
    Akbari, Omid
    CHEST, 2023, 164 (04) : 4904A - 4904A
  • [30] Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression
    Yin, Chaoyun
    Pa, Yani
    Li, Guangyu
    Chen, Qiang
    Wang, Xizu
    He, Xijun
    Zhou, Huangao
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2024, 46 (03) : 417 - 423